Medindia
Advertisement

New Drug Targets Based on Genes for Oesophageal Cancer

by Ramya Rachamanti on February 5, 2019 at 1:52 PM

New Drug Targets Based on Genes for Oesophageal Cancer
Mutations that cause oesophageal adenocarcinoma (OAC) have been mapped in novel detail- revealing that more than half could be targeted by drugs currently in trials for other cancer types.

This research, published in Nature Genetics, could help stratify oesophageal cancer patients to give them more personalised therapies. This could provide options not currently available to patients beyond standard chemotherapy, radiotherapy or surgery.
Advertisement


Cancer Research UK researchers at the University of Cambridge used whole genome sequencing and whole exome sequencing* to map mutations in OAC, the main subtype of oesophageal cancer in England.

In the study, driver mutations for OAC were found in 99% of patients and more than 50% were sensitive to drugs (CDK4/6 inhibitors) already in clinical trials for breast cancer. This means phase II/III clinical trials to treat oesophageal cancer could be feasible in one to two years.
Advertisement

Interestingly, women were found to have more KRAS** mutations than men. These mutations are often seen in other cancer types, but are rarely found in oesophageal cancer. This could indicate a different subtype of the disease in women and suggest they may have a different prognosis or be eligible for other treatments.

Professor Rebecca Fitzgerald, Cancer Research UK funded scientist and lead researcher at the MRC Cancer Unit, said: "This research could completely shift the paradigm from giving oesophageal cancer patients the same chemotherapy that we know doesn't always work, to more targeted treatments based on individual characteristics of a patient's cancer.

"We are now designing clinical trials that provide real-time analysis of patients' genes to offer patients the best treatment based on their own genome.

"This research could also provide better options for older patients, who are more likely to develop oesophageal cancer, and who are often not fit enough for current treatment options."

Only around 12% of patients survive oesophageal cancer for 10 years or more***. This is partly due to late diagnosis, as symptoms often do not present until the cancer is advanced, and partly due to limited treatment options. Scientists have found that more people are developing OAC in several countries in Western Europe, including the UK - risk factors include obesity and smoking****.

Professor Karen Vousden, Cancer Research UK's chief scientist, said: "Research like this is crucial to improve treatment options and survival for patients facing a hard-to-treat cancer, such as oesophageal cancer.

"Understanding which mutations are causing the disease could lead to targeted treatments and earlier detection. This is something that would never have been possible without huge advances in technology."

Cancer Research UK is committed to funding more research on hard to treat cancers like oesophageal cancer, increasing spending from £5 million four years ago, to £16 million this year*****. In the UK, oesophageal cancer is the 13th most common cancer and the seventh most common cause of cancer death in the UK******.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Stroop Effect
Plant-Based Diet may Reduce the Risk of COVID-19
Lower Respiratory Tract Infections Linked to Obstructive Sleep Apnea in Children
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Cancer and Homeopathy Clinical Trials - Different Phases of the trial Signature Drug Toxicity Cancer Facts Cancer Tattoos A Body Art Drugs Banned in India Weaver Syndrome Common Lifestyle Habits that Cause Diseases 

Recommended Reading
Human Papillomavirus Linked to Oesophageal Cancer
According to research led by University of New South Wales (UNSW) academics, the human ......
Clinical Trials - Different Phases of the trial
Clinical trials serve as a vital component for improving the treatment of medical conditions as they...
Common Lifestyle Habits that Cause Diseases
Cigarette smoking, unhealthy diets, overuse of alcohol, and physical inactivity are some of the most...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Drugs Banned in India
Several drugs are either banned or withdrawn after introduction in the market....
Tattoos A Body Art
Tattoos are a rage among college students who sport it for the ‘cool dude’ or ‘cool babe’ look...
Weaver Syndrome
Weaver syndrome is a genetic disorder in which children show accelerated bone growth, advanced bone ...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use